Yani He
Impact in
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Renal Diseases and Glomerulopathies
- Aging top 5%
Papers in
- Nephrology 32
- Chronic Kidney Disease and Diabetes 14
- Renal Diseases and Glomerulopathies 13
- Dialysis and Renal Disease Management 11
- Acute Kidney Injury Research 8
-
- Advanced Glycation End Products research 8
Yani He
67 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 114
- Nephrology 626
- Aging 62
- Clinical Biochemistry 231
- Physiology 77
- Physiology 374
Countries citing papers authored by Yani He
This map shows the geographic impact of Yani He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yani He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yani He more than expected).
Fields of papers citing papers by Yani He
This network shows the impact of papers produced by Yani He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yani He. The network helps show where Yani He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yani He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 44 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 1 | |
| 13 | Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer | 2020 | 1 |
| 14 | 2020 | 25 | |
| 15 | Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis | 2019 | 2 |
| 16 | 2018 | 19 | |
| 17 | 2018 | 6 | |
| 18 | 2017 | 1 | |
| 19 | 2017 | 97 | |
| 20 | 2016 | 1 |
About Yani He
Yani He is a scholar working on Nephrology, Clinical Biochemistry, Aging, Pathology and Forensic Medicine and Physiology, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (14 papers), Renal Diseases and Glomerulopathies (13 papers), Dialysis and Renal Disease Management (11 papers), Acute Kidney Injury Research (8 papers), Advanced Glycation End Products research (8 papers), Telomeres, Telomerase, and Senescence (7 papers), Biomedical Research and Pathophysiology (6 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Nephrology (626 citations), Aging (62 citations), Clinical Biochemistry (231 citations), Physiology (77 citations) and Physiology (374 citations). Yani He has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jurong Yang, Li-Rong Lin, Kehong Chen, Jian‐Guo Zhang, Guangyan Cai, Huanzi Dai, Jun Zhan, Kailong Li, Xiangmei Chen and Wenda Gao. Their work appears in journals such as The FASEB Journal, Scientific Reports, Kidney & Blood Pressure Research, Clinical Immunology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.